Medicine Overview of Alrubicin Injection
Nausea, Vomiting, Loss of appetite, Low blood platelets, Hair loss, Anemia (low number of red blood cells), Diarrhoea, Discoloration of urine, Mucosal inflammation, Stomatitis (Inflammation of the mouth), Febrile neutropenia, Decreased white blood cell count (neutrophils).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Alrubicin 150mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
In Depth Information on Alrubicin Injection
- Use appropriate contraception during treatment with epirubicin, if you are women of childbearing potential.
- Male patients should not to father a child during and for 6 months after stopping epirubicin treatment.
- Inform you doctor if you have or had suffered problems with your heart, liver or if you have severe infection such as urinary infection.
- Do not drink fluids for 12 hours before the treatment if epirubicin is to be used in the bladder.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Alrubicin Injection related warnings
Taking Epirubicin together with alcohol may cause liver problems.
WEIGH RISKS VS BENEFITS
Alrubicin 150mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Alrubicin 150mg Injection is unsafe to use during lactation.
Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Do not drive unless you are feeling well.
Alrubicin 150mg Injection may cause episodes of nausea and vomiting, which can temporarily lead to an impairment of the ability to drive.
Alrubicin 150mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Alrubicin 150mg Injection may not be needed in these patients. Please consult your doctor.
Lower doses may be considered in patients with serum creatinine > 5 mg/dL.
Alrubicin 150mg Injection should be used with caution in patients with liver disease. Dose adjustment of Alrubicin 150mg Injection may be needed. Please consult your doctor.
Use of Alrubicin 150mg Injection is not recommended in patients with severe liver disease.
User Submitted Feedback For Alrubicin 150mg Injection
What are you using Alrubicin Injection for?
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Alrubicin 150mg Injection. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Frequently asked questions about Alrubicin Injection
Yes, Alrubicin is a vesicant; it may cause tissue blistering if it leaks out of the vein
Yes, Alrubicin belongs to anthracycline class of anti-cancer medicines
Alrubicin and doxorubicin are both anticancer agents that belong to the anthracycline group
Alrubicin is an anticancer antibiotic
Alrubicin is used in the treatment of various cancers including cancer of the breast, ovary, stomach, lung, bowel or rectum, malignant lymphomas (a type of blood cancer of infection-fighting cells of the blood) such as Hodgkin's disease and non-Hodgkin's lymphoma, leukemia (blood cancer), multiple myeloma (a type of blood cancer of infection-fighting cells of the blood). It may be used in bladder cancers and to prevent reoccurrence of bladder cancer after surgery
Alrubicin is made from natural products produced by species of soil fungus Streptomyces
Alrubicin is given by injection into the vein or through a catheter into the bladder
Alrubicin is effective in the treatment of various cancers including cancer of the breast, ovary, stomach, lung, bowel or rectum, malignant lymphomas (a type of blood cancer of infection-fighting cells of the blood) such as Hodgkin's disease and non-Hodgkin's lymphoma, leukemia (blood cancer), multiple myeloma (a type of blood cancer of infection-fighting cells of the blood). It may be used in bladder cancers and to prevent reoccurrence of bladder cancer after surgery. It effectively slows or stops the growth of cancer cells in the body
The price of Alrubicin may vary depending upon the brand prescribed to you. Please read the instruction on the package for the correct price of the product.
One of the following vendor pharmacies will deliver Alrubicin 150mg Injection: MAX, WHL, AYM, PTI, NVL, ABP, EMB, JIV, SGH, ENP, MAK, KIS, SBA, SHD, BGS, RHW, BIO, DPP, EVP, BAL, NSL, RPP, SAF, DGN, PRN, BMJ, INC, MMS, EQN, SHC, RSA, NNH, HIP, NVY, AGT, BTM, ZVP, RWP, SCH, RDR, SWP, UBL, LCC, JHC, GHR, JVO, GPP, GPT, WSI, QLF, DHP, ANT, BLE, HEX, MSD, NAS, PMA, RKS, DPL, P2P, MLC, CHP, NDP, IAD, PWN, SVS, USF, HMP, SRG, BLS, BHM, SLN, PPR, JSL, HBV, MDO, SMN, BHP, BBS, GTC, RUS, VNS, HTS, MAP, LHA, AMR, THP, DFP, 9T9, SPD, RJH, MDH, MPC, HSP, OLT, GBL, JBT, IPL, HZF, AAR, AVS, KHH, RPI, JVN, BAP, DVH, SDM, SYN, HPC, HGI, CLT, KMC, NNP, VRS, DZY, TFP, SWA, TRP, RHL, HAT, PVP, AYU, VDH, GTK, AWS, EPS, TOM, BHS, ATL, AAY, OHM, ZPR, MAM, LMS, NXG, SGC, RSS, STA, TNH, BSN, VJS, PLT, ATP, SSA, RDH, SVH, DYG, ADT, NTB, FGH, OWP, HNP, ARD, SBL, NWP, DAO, GNC, PEN, SJP, PNT, DHR, ZEL, OIP, UMP, BDN, ESY, KHC, QTM